𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroleptic malignant syndrome associated with Olanzapine therapy: a case report

✍ Scribed by Stephen C Stanfield; Troy Privette


Book ID
117561397
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
53 KB
Volume
19
Category
Article
ISSN
0736-4679

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Olanzapine associated weight gain, Hyper
✍ Rhonda Malyuk; Bruce Gibson; Ric M. Procyshyn; Nirmal Kang πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 47 KB

## Abstract We describe here a case of olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome in a 64 year‐old woman with a significant medical history. Eighteen weeks after initiating olanzapine, Mrs X lost glycemic control, exhibited signs and symptoms consistent with

Neuroleptic malignant syndrome with olan
✍ M. Samir Arnaout; Fouad P. Antun; Khalil Ashkar πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 39 KB

A 30-year-old white man with schizophrenia developed anorexia and nausea, and was admitted to hospital for confusion and delirium. He was on olanzapine, 10 days prior to admission. On admission, typical neuroleptic malignant syndrome (NMS) developed with elevated body temperature (39.7 degrees C), o

Olanzapine induced neuroleptic malignant
✍ AleΕ‘ Kogoj; Ingrid Velikonja πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 79 KB

## Abstract Neuroleptic malignant syndrome is the rarest and the most serious of the neuroleptic induced movement disorders. Although potent neuroleptics are more frequently associated with NMS, atypical antipsychotic drugs may also be a cause of NMS. Three databases were searched using the terms β€˜